Radiation Dose Management Market Size, Share & Trends by 2028
Se prevé que el mercado de gestión de dosis de radiación alcance los 646,87 millones de dólares en 2028, frente a los 270,32 millones de dólares de 2021; Se estima que crecerá a una tasa compuesta anual del 13,3% durante 2021-2028.
La radioterapia es una rama esencial de la ciencia médica. Diversas enfermedades como el cáncer, las enfermedades cardiovasculares, etc. se diagnostican y tratan mediante ondas electromagnéticas. Se utiliza ampliamente para tratar diferentes tipos de cáncer. Sin embargo, la radioterapia también tiene efectos secundarios. Por lo tanto, controlar la dosis de radiación correcta es muy esencial en cualquier procedimiento médico basado en radiación. La dosis de radiación es la cantidad de radiación que se arroja al paciente. La gestión de dosis de radiación comprende información sobre software de registro de dosis de radiación; monitoreo de dosis del personal en tiempo real; Cumplimiento normativo; y tecnologías de reducción de dosis, como el software de reconstrucción interactiva.
El crecimiento del mercado de gestión de dosis de radiación se atribuye a las crecientes preocupaciones relacionadas con la exposición a la radiación y los crecientes casos de cáncer que requieren radioterapia. Sin embargo, los desafíos organizativos y la falta de evaluaciones comparativas para la optimización de dosis obstaculizan el crecimiento del mercado.
Personalice la investigación para adaptarla a sus necesidades
Podemos optimizar y adaptar el análisis y el alcance que no se cumplen a través de nuestras ofertas estándar. Esta flexibilidad le ayudará a obtener la información exacta que necesita para la planificación y la toma de decisiones de su negocio.
Mercado de gestión de dosis de radiación: ideas estratégicas
CAGR (2021 - 2028)13,3%- Tamaño del mercado 2021
US$ 270,32 millones - Tamaño del mercado 2028
US$ 646,87 millones
Dinámica del mercado
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Jugadores claves . Jugadores principales
- Corporación FUJIFILM Holdings
- Bayer AG
- Bracco Imaging SpA
- GE atención sanitaria
- Koninklijke Philips NV
- Medcuadrado
- Corporación Novarad
- QAELUM INC
- Sectra AB
Panorama regional
- América del norte
- Europa
- Asia-Pacífico
- América del Sur y Central
- Medio Oriente y África
Segmentación de mercado
- Servicios de gestión de dosis de radiación y software de gestión de dosis de radiación
- Tomografía computarizada
- Radiación y mamografía
- Fluroscopia y mamografía
- Otros
- hospitales
- Institutos médicos y de investigación
- Otros
- El PDF de muestra muestra la estructura del contenido y la naturaleza de la información con análisis cualitativo y cuantitativo.
Perspectivas del mercado
Enfoque creciente en radiología intervencionista y medicina nuclear
Los rápidos avances en tecnología médica, fabricación de dispositivos y equipos de imágenes han dado como resultado el perfeccionamiento de los procedimientos originales con mejores técnicas y una ampliación de las indicaciones de los procedimientos. Se han desarrollado nuevas técnicas y algunas técnicas se migran a otras modalidades de imagen. Debido a la alta eficiencia de las imágenes, en todo el mundo se están realizando más procedimientos de medicina nuclear y radiológica intervencionista. Según la Sociedad de Medicina Nuclear, cada año se realizan aproximadamente 20 millones de procedimientos de medicina nuclear en los EE. UU. Según informa la Asociación Nuclear Mundial, más de 10.000 hospitales en todo el mundo utilizan radioisótopos en medicina y el 90% de los procedimientos con radioisótopos son de diagnóstico. Actores del mercado como Bayer Healthcare y Sectra Medical Systems ofrecen software de gestión de dosis específicamente para RDM en imágenes intervencionistas y medicina nuclear. Por lo tanto, el creciente enfoque en la radiología intervencionista y la medicina nuclear está brindando oportunidades para el crecimiento del mercado.
Información basada en servicios/software
Basado en servicios/software, el mercado mundial de gestión de dosis de radiación se ha segmentado en servicios de gestión de dosis de radiación y software de gestión de dosis de radiación. El segmento de software de gestión de dosis de radiación tuvo la mayor participación del mercado en 2021 y se prevé que registre una tasa compuesta anual del 13,6% en el mercado durante el período de pronóstico.
Perspectivas de base media
Según el medio, el mercado mundial de gestión de dosis de radiación se segmenta en tomografía computarizada, radiación y mamografía, fluoroscopia y mamografía, y otros medios. El segmento de tomografía computarizada tuvo la mayor participación del mercado en 2021 y se prevé que registre una tasa compuesta anual del 13,8% en el mercado durante el período de pronóstico.
Alcance del informe de mercado de Gestión de dosis de radiación
Atributo del informe | Detalles |
---|---|
Tamaño del mercado en 2021 | US$ 270,32 millones |
Tamaño del mercado para 2028 | US$ 646,87 millones |
CAGR global (2021 - 2028) | 13,3% |
Información histórica | 2019-2020 |
Período de pronóstico | 2022-2028 |
Segmentos cubiertos | Por servicio/software
|
Regiones y países cubiertos | América del norte
|
Líderes del mercado y perfiles clave de empresas |
|
- El PDF de muestra muestra la estructura del contenido y la naturaleza de la información con análisis cualitativo y cuantitativo.
Información basada en el usuario final
Según el usuario final, el mercado de gestión de dosis de radiación está segmentado en hospitales, institutos médicos y de investigación, entre otros. El segmento hospitalario tuvo la mayor participación del mercado en 2021 y se estima que registrará la CAGR más alta del 13,6% en el mercado durante el período de pronóstico.
Los lanzamientos y aprobaciones de productos son estrategias comúnmente adoptadas por las empresas para expandir su presencia global y sus carteras de productos. Además, los actores del mercado de gestión de dosis de radiación se centran en la estrategia de asociación para ampliar su clientela, lo que, a su vez, les permite mantener su marca en todo el mundo.
Perfiles de empresa
- Corporación FUJIFILM Holdings
- Bayer AG
- Bracco Imaging SpA
- GE atención sanitaria
- Koninklijke Philips NV
- Medcuadrado
- Corporación Novarad
- QAELUM INC
- Sectra AB
- PACSHealth, LLC
Radiation Dose Management Market Report Scope
Report Attribute | Details |
---|---|
Market size in | US$ 270.32 Million |
Market Size by | US$ 646.87 Million |
Global CAGR | 13.3% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Servicio/Software
|
Regions and Countries Covered |
América del Norte
|
Market leaders and key company profiles |
|
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Radiation Dose Management software segment dominated the global radiation dose management market and held the largest revenue share of 77.67% in 2021.
Radiation dose management involves services and software that keep records of the radiation doses, real time dose monitoring, regulatory compliance. It is an information technology which is considerate in lowering the dose with integrative reconstruction software. The software assists to find the right way to radiation dose for a patient to get treated by the integration of medical technology and insightful data & services.
Key factors that are driving the growth of this market are growing concerns related to radiation exposure, and rising cases of cancer demanding radiation therapy.
The Computed Tomography segment dominated the global radiation dose management market and held the largest revenue share of 42.54% in 2021.
The hospitals segment dominated the global radiation dose management market and accounted for the largest revenue share of 51.14% in 2021.
Global radiation dose management market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for radiation dose management. The market growth in the country is attributed to the factors such as the stringent legislative and accreditation requirements regarding the reporting and optimization of radiation doses, high adoption of HCIT technologies, and the presence of stringent regulatory requirements regarding patient safety. And, North America is the fastest-growing region growing at the CAGR of 13.8% during the forecast period.
The radiation dose management market majorly consists of the players such as FUJIFILM Holdings Corporation; Bayer AG; Bracco Imaging S.p.A; GE Healthcare; Koninklijke Philips N.V.; Medsquare; Novarad Corporation; QAELUM INC; Sectra AB; PACSHealth, LLC: among others.
List of Companies - Radiation Dose Management Market
- FUJIFILM Holdings Corporation
- Bayer AG
- Bracco Imaging S.p.A
- GE Healthcare
- Koninklijke Philips N.V.
- Medsquare
- Novarad Corporation
- QAELUM INC
- Sectra AB
- PACSHealth, LLC
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.